Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Total Brain N-Acetylaspartate, A New Measure of Disease Load in MS
Neurol 54:15-19, Gonen,O.,et al, 2000
A New Metabolite Contributing to N-Acetyl Signal in 1H MRS of the Brain in Salla Disease
Neurol 52:1668-1672, Varho,T.,et al, 1999
Axonal Transection in the Lesions of Multiple Sclerosis
NEJM 338:278-285, 3231998., Trapp,B.D.,et al, 1998
Estimation of Brainstem Neuronal Loss in ALS with in Vivo Proton Magnetic Resonance Spectroscopy
Neurol 50:72-77, Cwik,V.A.,et al, 1998
White Matter Disease Induced by High-Dose Chemotherapy:MR Imaging & Proton Spectroscopy
AJNR 19:217-221, Brown,M.S.,et al, 1998
Functional & Metabolic Analysis of Cerebral Ischemia Using Magnetoencephalography & Proton MR Spectroscopy
Ann Neurol 42:554-563, 5391997., Kamada,K.,et al, 1997
Magnetic Resonance Spectroscopy of N-Acetylaspartate in Hypoxic-Ischemic Encephalopathy
Ann Neurol 35:490-494, Graham,S.H.,et al, 1994
Detection of Cortical Neuron Loss in Motor Neuron Disease by Proton Magnetic Resonance Spectroscopic Imaging in Vivo
Neurol 44:1933-1938, Pioro,E.P.,et al, 1994